| Record ID | marc_columbia/Columbia-extract-20221130-009.mrc:28560708:1098 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-009.mrc:28560708:1098?format=raw |
LEADER: 01098cam a2200301 4500
001 4027651
005 20221027021435.0
008 751125s1941 nju 000 0 eng d
010 $a 42003858
035 $a(OCoLC)ocm01854476
035 $9AJY5860HS
035 $a(NNC)4027651
035 $a4027651
040 $aFQG$cFQG$dZCH
050 00 $aRM666.S85$bM43
082 0 $a616.952
110 2 $aMerck & Co.$0http://id.loc.gov/authorities/names/n81093623
245 10 $aClinical use of sulfonamide compounds in the treatment of gonococcal infections.
260 $aRahway, N. J. :$bMerck & co. inc.,$c1941.
300 $a44 numbered leaves ;$c28 x 22 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
500 $aReproduced from type-written copy.
504 $aBibilography: leaves 35-44.
650 0 $aSulfonamides.$0http://id.loc.gov/authorities/subjects/sh85130353
650 0 $aGonorrhea.$0http://id.loc.gov/authorities/subjects/sh85055863
650 0 $aNeisseria gonorrhoeae.$0http://id.loc.gov/authorities/subjects/sh85090674
852 00 $boff,hsl$hRM671.S5$iM5323